Merz has developed leading treatment options for skin care and dermatology, making us a market leader in many countries, especially in scar therapy and hair loss. Merz is continually working to advance the quality of patient care in dermatology, and we have a strong reputation in the space for delivering excellent, effective medical products that treat a range of dermatological concerns.
A frequent complication in chronic liver diseases is hepatic encephalopathy (HE). Merz developed the substance L-ornithine L-aspartate, which relieves the symptoms of HE and is today regarded as a standard therapy for this disease.
Alzheimer’s disease (AD) is the most common form of dementia. With Memantine, Merz developed the first active compound worldwide for the treatment of moderate to severe AD. It was first approved for Alzheimer’s disease in EU in 2002, and is today essential to the treatment of AD.
Parkinson’s disease (PD) is one of the most common disorders of the central nervous system. Amantadine is an NMDA-receptor antagonist blocking the pathological glutamatergic activity and thus restoring/improving the glutamatergic-dopaminergic balance. For the potentially life-threatening situation of akinetic crisis in PD, intravenously administered amantadine has proven helpful.
Merz consumer care
With the well-known brands Merz Spezial and tetesept, Merz Consumer Care offers a broad range of products for healthy skin, hair and nails as well as self-medication like health care baths. The products distinguish themselves by the combination of traditional natural remedies and state-of-the-art scientific research.